A review of the effects of ticagrelor on adenosine concentration and its clinical significance
Background Ticagrelor is an oral antiplatelet drug that can reversibly bind to the platelet P2Y12 receptor. Ticagrelor is metabolized mainly by CYP3A4 and produces a rapid blood concentration-dependent platelet inhibitory effect. Unlike other P2Y12 receptor antagonists, many clinical features of tic...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Published: |
Springer Heidelberg
2021
|
| Subjects: | |
| Online Access: | http://eprints.um.edu.my/28207/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|